114 related articles for article (PubMed ID: 35334457)
1. Socioeconomic factors associated with pediatric moyamoya disease hospitalizations: a nationwide cross-sectional study.
Raygor KP; Phelps RRL; Rutledge C; Raper DMS; Molinaro A; Fox CK; Gupta N; Abla AA
J Neurosurg Pediatr; 2022 Jun; 29(6):602-611. PubMed ID: 35334457
[TBL] [Abstract][Full Text] [Related]
2. Socioeconomic Inequities in the Surgical Management of Moyamoya Disease.
Chiu R; Chaker A; McGuire LS; Kwasnicki A; Du X; Alaraj A; Charbel FT
World Neurosurg; 2021 Nov; 155():e188-e195. PubMed ID: 34400326
[TBL] [Abstract][Full Text] [Related]
3. Socioeconomic and demographic disparities of moyamoya disease in the United States.
Ghaffari-Rafi A; Ghaffari-Rafi S; Leon-Rojas J
Clin Neurol Neurosurg; 2020 May; 192():105719. PubMed ID: 32045710
[TBL] [Abstract][Full Text] [Related]
4. Risk factors associated with the surgical management of craniopharyngiomas in pediatric patients: analysis of 1961 patients from a national registry database.
Bakhsheshian J; Jin DL; Chang KE; Strickland BA; Donoho DA; Cen S; Mack WJ; Attenello F; Christian EA; Zada G
Neurosurg Focus; 2016 Dec; 41(6):E8. PubMed ID: 27903117
[TBL] [Abstract][Full Text] [Related]
5. National Analysis of 2454 Pediatric Moyamoya Admissions and the Effect of Hospital Volume on Outcomes.
Titsworth WL; Scott RM; Smith ER
Stroke; 2016 May; 47(5):1303-11. PubMed ID: 27048697
[TBL] [Abstract][Full Text] [Related]
6. Racial and socioeconomic disparities in the advanced treatment of medically intractable pediatric epilepsy.
Kandregula S; Terrell D; Beyl R; Freelin A; Guthikonda B; Notarianni C; Toms J
Neurosurg Focus; 2022 Oct; 53(4):E2. PubMed ID: 36183182
[TBL] [Abstract][Full Text] [Related]
7. Extracranial-Intracranial Bypass for Moyamoya Disease: The Influence of Racial and Socioeconomic Disparities on Outcomes - A National Inpatient Sample Analysis.
Rios-Zermeno J; Ghaith AK; El Hajj VG; Soltan F; Greco E; Michaelides L; Lin MP; Meschia JF; Akinduro OO; Bydon M; Bendok BR; Tawk RG
World Neurosurg; 2024 Feb; 182():e624-e634. PubMed ID: 38061545
[TBL] [Abstract][Full Text] [Related]
8. Pediatric acquired demyelinating syndrome (ADS) in inpatient hospital settings: The hospitalization rate, costs, and outcomes in the US.
Minegishi M; Takahashi T; Testa M
Mult Scler Relat Disord; 2019 Sep; 34():150-157. PubMed ID: 31295724
[TBL] [Abstract][Full Text] [Related]
9. Socioeconomic Factors Are Associated With Severity of Hospitalization in Pediatric Lupus: An Analysis of the 2016 Kids' Inpatient Database.
Soulsby WD; Lawson E; Okumura M; Pantell MS
Arthritis Care Res (Hoboken); 2023 Oct; 75(10):2073-2081. PubMed ID: 36971263
[TBL] [Abstract][Full Text] [Related]
10. Trends in hospitalizations and epidemiological characteristics of adults Moyamoya disorder in the United States.
Patel SD; Desai N; Rane S; Patel N; Desai R; Mehta T; Ollenschleger MD; Nanda A; Starke RM; Khandelwal P
J Neurol Sci; 2020 Dec; 419():117165. PubMed ID: 33059298
[TBL] [Abstract][Full Text] [Related]
11. Payer and race/ethnicity influence length and cost of childhood cancer hospitalizations.
Whittle SB; Lopez MA; Russell HV
Pediatr Blood Cancer; 2019 Jul; 66(7):e27739. PubMed ID: 30989762
[TBL] [Abstract][Full Text] [Related]
12. Inpatient health care utilization in the United States among children, adolescents, and young adults with nephrotic syndrome.
Gipson DS; Messer KL; Tran CL; Herreshoff EG; Samuel JP; Massengill SF; Song P; Selewski DT
Am J Kidney Dis; 2013 Jun; 61(6):910-7. PubMed ID: 23434062
[TBL] [Abstract][Full Text] [Related]
13. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053
[TBL] [Abstract][Full Text] [Related]
14. Rates of Influenza-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death by Race and Ethnicity in the United States From 2009 to 2019.
O'Halloran AC; Holstein R; Cummings C; Daily Kirley P; Alden NB; Yousey-Hindes K; Anderson EJ; Ryan P; Kim S; Lynfield R; McMullen C; Bennett NM; Spina N; Billing LM; Sutton M; Schaffner W; Talbot HK; Price A; Fry AM; Reed C; Garg S
JAMA Netw Open; 2021 Aug; 4(8):e2121880. PubMed ID: 34427679
[TBL] [Abstract][Full Text] [Related]
15. Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease.
Chen JB; Liu Y; Zhou LX; Sun H; He M; You C
J Neurosurg; 2016 May; 124(5):1215-20. PubMed ID: 26406790
[TBL] [Abstract][Full Text] [Related]
16. Treatment course and outcomes after revascularization surgery for moyamoya disease in adults.
Kahn A; Kaur G; Stein L; Tuhrim S; Dhamoon MS
J Neurol; 2018 Nov; 265(11):2666-2671. PubMed ID: 30196325
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
[TBL] [Abstract][Full Text] [Related]
18. Differences in surgical outcomes for patients with craniosynostosis in the US: impact of socioeconomic variables and race.
Shweikeh F; Foulad D; Nuño M; Drazin D; Adamo MA
J Neurosurg Pediatr; 2016 Jan; 17(1):27-33. PubMed ID: 26407174
[TBL] [Abstract][Full Text] [Related]
19. Does Universal Insurance and Access to Care Influence Disparities in Outcomes for Pediatric Patients with Osteomyelitis?
Young JD; Dee EC; Levine A; Sturgeon DJ; Koehlmoos TP; Schoenfeld AJ
Clin Orthop Relat Res; 2020 Jul; 478(7):1432-1439. PubMed ID: 31725027
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Newly Developed Cerebral Infarction After Surgical Revascularization for Adults with Moyamoya Disease.
Park W; Ahn JS; Lee HS; Park JC; Kwun BD
World Neurosurg; 2016 Aug; 92():65-73. PubMed ID: 27020972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
